|
[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Klein, C.A. (2020) Cancer Progression and the Invisible Phase of Meta-static Colonization. Nature Reviews Cancer, 20, 681-694. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lakemeyer, L., Sander, S., Wittau, M., et al. (2021) Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer. Diseases, 9, Article No. 21. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Luo, P., Wu, S., Yu, Y., et al. (2020) Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage. Pathology and Oncology Research, 26, 599-603. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Zhang, M., Cheng, S., Jin, Y., et al. (2021) Roles of CA125 in Diagnosis, Prediction, and Oncogenesis of Ovarian Cancer. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1875, Article ID: 188503. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
O’Shea, A.S. (2022) Clinical Staging of Ovarian Cancer. Meth-ods in Molecular Biology, 2424, 3-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Li, C., Holman, J.B., Shi, Z., et al. (2023) On-Chip Modeling of Tumor Evolution: Advances, Challenges and Opportunities. Materials Today Bio, 21, Article ID: 100724. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Shen, C., Rawal, S., Brown, R., et al. (2023) Automatic Detec-tion of Circulating Tumor Cells and Cancer Associated Fibroblasts Using Deep Learning. Scientific Reports, 13, Article No. 5708. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Shaik, M.R., Sagar, P.R., Shaik, N.A., et al. (2023) Liquid Bi-opsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring. International Journal of Molecular Sciences, 24, Article No. 10644. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Han, H.J., Sung, J.Y., Kim, S.H., et al. (2021) Fibronectin Regulates Anoikis Resistance via Cell Aggregate Formation. Cancer Letters, 508, 59-72. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Alemzadeh, E., Allahqoli, L., Dehghan, H., et al. (2023) Circulat-ing Tumor Cells and Circulating Tumor DNA in Breast Cancer Diagnosis and Monitoring. Oncology Research, 31, 667-675. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Ju, S., Chen, C., Zhang, J., et al. (2022) Detection of Cir-culating Tumor Cells: Opportunities and Challenges. Biomarker Research, 10, Article No. 58. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Rushton, A.J., Nteliopoulos, G., Shaw, J.A., et al. (2021) A Re-view of Circulating Tumour Cell Enrichment Technologies. Cancers (Basel), 13, Article No. 970. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Marcuello, M., Vymetalkova, V., Neves, R.P.L., et al. (2019) Cir-culating Biomarkers for Early Detection and Clinical Management of Colorectal Cancer. Molecular Aspects of Medicine, 69, 107-122. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Xia, W., Li, H., Li, Y., et al. (2021) In Vivo Coinstantaneous Iden-tification of Hepatocellular Carcinoma Circulating Tumor Cells by Dual-Targeting Magnetic-Fluorescent Nanobeads. Nano Letters, 21, 634-641. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wang, Z., Sun, N., Liu, H., et al. (2019) High-Efficiency Isola-tion and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluo-rescent-Magnetic Nanoparticles. ACS Applied Materials & Interfaces, 11, 39586-39593. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Hu, L., Chen, X., Chen, M., et al. (2021) Enrichment and Detection of Circulating Tumor Cells by Immunomagnetic Beads and Flow Cytometry. Biotechnology Letters, 43, 25-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wang, C., Xu, Y., Li, S., et al. (2022) Designer Tetrahedral DNA Framework-Based Microfluidic Technology for Multivalent Capture and Release of Circulating Tumor Cells. Ma-terials Today Bio, 16, Article ID: 100346. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Tamminga, M., Andree, K.C., Hiltermann, T.J.N., et al. (2020) Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET. Cancers (Basel), 12, Article No. 896. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Deng, Z., Wu, S., Wang, Y., et al. (2022) Circulating Tumor Cell Isolation for Cancer Diagnosis and Prognosis. EBioMedicine, 83, Article ID: 104237. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Wu, S., Gu, L., Qin, J., et al. (2020) Rapid Label-Free Isolation of Circulating Tumor Cells from Patients’ Peripheral Blood Using Electrically Charged FeO Nanoparticles. ACS Applied Materials & Interfaces, 12, 4193-4203. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Acheampong, E., Abed, A., Morici, M., et al. (2022) Evaluation of PD-L1 Expression on Circulating Tumour Cells in Small-Cell Lung Cancer. Translational Lung Cancer Research, 11, 440-451. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Liu, Z., Huang, Y., Liang, W., et al. (2021) Cascaded Filter De-terministic Lateral Displacement Microchips for Isolation and Molecular Analysis of Circulating Tumor Cells and Fusion Cells. Lab on a Chip, 21, 2881-2891. [Google Scholar] [CrossRef]
|
|
[24]
|
Sonoda, T., Yanagitani, N., Suga, K., et al. (2020) A Novel System to Detect Circulating Tumor Cells Using Two Different Size-Selective Microfilters. Anticancer Research, 40, 5577-5582. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Ning, D., Cui, K., Liu, M., et al. (2021) Comparison of Cell Search and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer. Medical Science Monitor, 27, e926565. [Google Scholar] [CrossRef]
|
|
[26]
|
Chen, K., Dopico, P., Varillas, J., et al. (2019) Integration of Lateral Filter Arrays with Immunoaffinity for Circulating-Tumor-Cell Isolation. Angewandte Chemie International Edition in English, 58, 7606-7610. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Nasiri, R., Shamloo, A. and Akbari, J. (2021) Design of a Hybrid In-ertial and Magnetophoretic Microfluidic Device for CTCs Separation from Blood. Micromachines (Basel), 12, Article No. 877. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Reza, K.K., Dey, S., Wuethrich, A., et al. (2021) In Situ Single Cell Proteomics Reveals Circulating Tumor Cell Heterogeneity during Treatment. ACS Nano, 15, 11231-11243. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Nikanjam, M., Kato, S. and Kurzrock, R. (2022) Liquid Biopsy: Current Technology and Clinical Applications. Journal of Hematology & Oncology, 15, Article No. 131. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Rashed, W.M., Kandeil, M.A.M., Mahmoud, M.O., et al. (2020) Hepatocellular Carcinoma (HCC) in Egypt: A Comprehensive Overview. Journal of the Egyptian National Cancer Insti-tute, 32, Article No. 5. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Ahn, J.C., Teng, P.C., Chen, P.J., et al. (2021) Detection of Cir-culating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Hepatology, 73, 422-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Qi, L.N., Xiang, B.D., Wu, F.X., et al. (2018) Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Cancer Re-search, 78, 4731-4744. [Google Scholar] [CrossRef]
|
|
[33]
|
Cui, K., Ou, Y., Shen, Y., et al. (2020) Clinical Value of Circulating Tumor Cells for the Diagnosis and Prognosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis. Medicine (Baltimore), 99, e22242. [Google Scholar] [CrossRef]
|
|
[34]
|
Chen, V.L., Xu, D., Wicha, M.S., et al. (2020) Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review. Clinical Gastroenterology and Hepatology, 18, 2879-2902.e9. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
El-Mezayen, H.A., El-Kassas, M., El-Taweel, F.M., et al. (2022) Diagnostic Performance of Circulating Tumor Cells for Predicting of Hepatocellular Carcinoma in Hepatitis C Vi-rus-High Risk Patients: Role of Liquid Biopsy. Asian Pacific Journal of Cancer Prevention, 23, 2541-2549. [Google Scholar] [CrossRef]
|
|
[36]
|
Cao, J., Zhao, M., Liu, J., et al. (2019) RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog. Theranostics, 9, 811-828. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Lei, Y., Wang, X., Sun, H., et al. (2021) Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels with Recurrence of Hepatocellular Carcinoma. Frontiers in Oncology, 11, Article ID: 601668. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Lee, Y.T., Sun, N., Kim, M., et al. (2022) Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting. Liver Transplantation, 28, 200-214. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Raza, A., Khan, A.Q., Inchakalody, V.P., et al. (2022) Dynamic Liquid Bi-opsy Components as Predictive and Prognostic Biomarkers in Colorectal Cancer. Journal of Experimental & Clinical Cancer Research, 41, Article No. 99. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Mirza, S., Bhadresha, K., Mughal, M.J., et al. (2023) Liquid Bi-opsy Approaches and Immunotherapy in Colorectal Cancer for Precision Medicine: Are We There Yet. Frontiers in On-cology, 12, Article ID: 1023565. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Yang, C., Zhuang, W., Hu, Y., et al. (2018) Clinical Significance of Peripheral Circulating Tumor Cell Counts in Colorectal Polyps and Non-Metastatic Colorectal Cancer. World Journal of Surgical Oncology, 16, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Yan, S., Guo, W., Liu, Y., et al. (2022) The Role of Folate Re-ceptor-Positive Circulating Tumor Cell Analysis in the Diagnosis of Colorectal Cancer: A Retrospective Cohort Study. International Journal of Clinical Oncology, 27, 538-544. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Li, Z., Cai, J., Zhao, Y., et al. (2022) Folate Receptor-Positive Circulating Tumor Cells in the Preoperative Diagnosis of Inde-terminate Pulmonary Nodules. Journal of Clinical Laboratory Analysis, 36, e24654. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Cheng, H., He, W., Yang, J., et al. (2020) Ligand-Targeted Polymerase Chain Reaction for the Detection of Folate Receptor-Positive Circulating Tumour Cells as a Potential Diagnostic Bi-omarker for Pancreatic Cancer. Cell Proliferation, 53, e12880. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Bidard, F.C., Kiavue, N., Ychou, M., et al. (2019) Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Re-sectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial. Cells, 8, Article No. 516. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Pan, R.J., Hong, H.J., Sun, J., et al. (2021) Detection and Clinical Value of Circulating Tumor Cells as an Assisted Prognostic Marker in Colorectal Cancer Patients. Cancer Man-agement and Research, 13, 4567-4578. [Google Scholar] [CrossRef]
|
|
[47]
|
Zhong, Y., Ma, T., Qiao, T., et al. (2021) Role of Phenotypes of Circulating Tumor Cells in the Diagnosis and Treatment of Colorectal Cancer. Cancer Management and Research, 13, 7077-7085. [Google Scholar] [CrossRef]
|
|
[48]
|
Karimi, N., Oloomi, M. and Orafa, Z. (2020) Circulating Tumor Cells Detection in Patients with Early Breast Cancer Using MACS Immunomagnetic Flow Cytometry. Avicenna Journal of Medical Biotechnology, 12, 148-156.
|
|
[49]
|
Jin, T., Chen, Y., Chen, Q.Y., et al. (2023) Circulating Tumor Cells in Pe-ripheral Blood as a Diagnostic Biomarker of Breast Cancer: A Meta-Analysis. Frontiers in Oncology, 13, Article ID: 1103146. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Jin, L., Zhao, W., Zhang, J., et al. (2020) Evaluation of the Diag-nostic Value of Circulating Tumor Cells with CytoSorter® CTC Capture System in Patients with Breast Cancer. Cancer Medicine, 9, 1638-1647. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Shao, X., Jin, X., Chen, Z., et al. (2022) A Comprehensive Comparison of Circulating Tumor Cells and Breast Imaging Modalities as Screening Tools for Breast Cancer in Chinese Women. Fron-tiers in Oncology, 12, Article ID: 890248. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Mäurer, M., Pachmann, K., Wendt, T., et al. (2021) Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radio-therapy of Breast Cancer Patients. Current Oncology, 28, 3507-3524. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Mäurer, M., Schott, D., Pizon, M., et al. (2022) Increased Circu-lating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer. Current Oncology, 30, 261-273. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Lisencu, L.A., Trancă, S., Bonci, E.A., et al. (2022) The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Lit-erature. Biomedicines, 10, Article No. 769. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Stefanovic, S., Deutsch, T.M., Riethdorf, S., et al. (2020) The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast Cancer. International Journal of Molecular Sciences, 21, Article No. 2161. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Wang, C., Mu, Z., Ye, Z., et al. (2020) Prognostic Value of HER2 Sta-tus on Circulating Tumor Cells in Advanced-Stage Breast Cancer Patients with HER2-Negative Tumors. Breast Cancer Research and Treatment, 181, 679-689. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Deutsch, T.M., Riethdorf, S., Fremd, C., et al. (2020) HER2-Targeted Therapy Influences CTC Status in Metastatic Breast Cancer. Breast Cancer Research and Treatment, 182, 127-136. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Liang, W., Chen, Z., Li, C., et al. (2021) Accurate Diagnosis of Pulmonary Nodules Using a Noninvasive DNA Methylation Test. Journal of Clinical Investigation, 131, e145973. [Google Scholar] [CrossRef]
|
|
[59]
|
Xu, C., Xu, X., Shao, W., et al. (2023) CTCs Detection and Whole-Exome Sequencing Might Be Used to Differentiate Benign and Malignant Pulmonary Nodules. Chinese Journal of Lung Cancer, 26, 449-460.
|
|
[60]
|
Duan, G.C., Zhang, X.P., Wang, H.E., et al. (2020) Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer. OncoTargets and Therapy, 13, 1931-1939. [Google Scholar] [CrossRef]
|
|
[61]
|
Marquette, C.H., Boutros, J., Benzaquen, J., et al. (2020) Circulating Tumour Cells as a Potential Biomarker for Lung Cancer Screening: A Prospective Cohort Study. The Lancet Respiratory Medicine, 8, 709-716.
|
|
[62]
|
Wu, C.Y., Lee, C.L., Wu, C.F., et al. (2020) Circulating Tumor Cells as a Tool of Minimal Residual Disease Can Predict Lung Cancer Recurrence: A Longitudinal, Prospective Trial. Diagnostics (Basel), 10, Arti-cle No. 144. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Wankhede, D., Grover, S. and Hofman, P. (2022) Circulating Tumor Cells as a Predictive Biomarker in Resectable Lung Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel), 14, Article No. 6112. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Frick, M.A., Feigenberg, S.J., Jean-Baptiste, S.R., et al. (2020) Cir-culating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy. Clinical Cancer Research, 26, 2372-2380. [Google Scholar] [CrossRef]
|
|
[65]
|
Pailler, E., Faugeroux, V., Oulhen, M., et al. (2019) Ac-quired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer. Clinical Cancer Research, 25, 6671-6682. [Google Scholar] [CrossRef]
|
|
[66]
|
Chen, J., Wang, H., Zhou, L., et al. (2022) A Combination of Circulating Tumor Cells and CA199 Improves the Diagnosis of Pancreatic Cancer. Journal of Clinical Laboratory Analysis, 36, e24341. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Cheng, R., Peng, Y., Sun, X., et al. (2023) Circulat-ing Tumor Cells as Diagnostic Markers of Early Gastric Cancer and Gastric Precancerous Lesions. Oncology, 101, 512-519. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Yang, Z., Bai, H., Hu, L., et al. (2022) Improving the Diagnosis of Prostate Cancer by Telomerase-Positive Circulating Tumor Cells: A Prospective Pilot Study. EClinicalMedicine, 43, Article ID: 101161. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Wang, Y., Yu, X., Hartmann, D., et al. (2020) Circulating Tu-mor Cells in Peripheral Blood of Pancreatic Cancer Patients and Their Prognostic Role: A Systematic Review and Me-ta-Analysis. HPB (Oxford), 22, 660-669. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Zhang, Y., Wang, F., Ning, N., et al. (2015) Patterns of Circulating Tumor Cells Identified by CEP8, CK and CD45 in Pancreatic Cancer. International Journal of Cancer, 136, 1228-1233. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Li, Z., Song, M., Han, S., et al. (2022) The Prognostic Role of Circulating Tumor Cells in Gastric Cancer: A Meta-Analysis. Frontiers in Oncology, 12, Article ID: 963091. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Yang, J., Ma, J., Jin, Y., et al. (2021) Development and Validation for Prognostic Nomogram of Epithelial Ovarian Cancer Recurrence Based on Circulating Tumor Cells and Epitheli-al-Mesenchymal Transition. Scientific Reports, 11, Article No. 6540. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Di Lorenzo, G., Zappavigna, S., Crocetto, F., et al. (2021) As-sessment of Total, PTEN, and AR-V7 Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Cas-tration-Resistant Prostate Cancer Receiving Enzalutamide. Clinical Genitourinary Cancer, 19, e286-e298. [Google Scholar] [CrossRef] [PubMed]
|